Skip to content

A study on Venpoosani nei and Thiriphala chooranam for the manageent of Leucorrhoea(White discharge)

AN OPEN RANDOMISED DOUBLE ARM CLINICAL TRIAL TO EVALUATE AND COMPARE THE EFFICACY OF SIDDHA HERBAL FORMULATIONS â??VENPOOSANI NEIâ?? (INTERNAL) VERSUS â??VENPOOSANI NEI (internal) WITH THIRIPHALA CHOORNAM WASH (external) IN â??VELLAI NOIâ?? FOR FEMALE PATIENTS ATTENDING SCRI - CHENNAI - VPNTPV

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043224
Enrollment
60
Registered
2022-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N889- Noninflammatory disorder of cervixuteri, unspecified

Interventions

Intervention1: Arm :1 : Mono therapy with Venpoosani nei (internal): 7.5 ml, Two times a day after food - Duration-40 days Control Intervention1: Arm: 2 : Combination therapy with Venpoosani nei (inte

Sponsors

Central Council for Research in Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age â?? 18 to 50 Years 2 Gender â?? Married Female 3 Thick whitish or yellowish or greenish discharge from vagina with foul smell 4 Itching and burning sensation in vulva 5 Vaginal swab test positive for micro-organism 6 Dysuria 7 Lower abdominal pain 8 Pain in lumbar region

Exclusion criteria

Exclusion criteria: 1.White discharge with bleeding 2.Ovarian cyst or tumor, prolapse 3.Pregnancy and lactation 4.Diabetes 5.Physiological vaginal discharge 6.Use of antibiotics or local vaginal formulation within the previous month

Design outcomes

Primary

MeasureTime frame
Trial is to show vaginal swab negative for micro-organismTimepoint: After 40 days

Secondary

MeasureTime frame
1.Reduction of signs and symptoms of vellai noi (leucorrhea) â?? (Severity score) 2.To assess whether administration of venpoosani nei alter the lipid levels by measuring lipid profile, before and after treatment. Timepoint: After 40 days

Countries

India

Contacts

Public ContactDr P Sathiyarajeswaran

Siddha Central Research Institute

crisiddha@gmail.com9443579540

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026